Cost-effectiveness analysis of therapy for symptomatic carotid occlusion: PET screening before selective extracranial-to-intracranial bypass versus medical treatment

Journal of Nuclear Medicine

Volumn 41, Issue 5, 2000, Pages 800-807

  Derdeyn, Colin P ^a   Gage, Brian F ^b   Grubb Jr , Robert L ^b   Powers, William J ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Carotid occlusion; Cost effectiveness; Oxygen extraction; PET; Screening

Indexed keywords

ARTICLE; BRAIN BLOOD FLOW; CAROTID ARTERY OBSTRUCTION; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STROKE;

CAROTID STENOSIS; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR ACCIDENT; COST-BENEFIT ANALYSIS; HUMANS; MARKOV CHAINS; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0034101961     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Powers WJ, Press GA, Grubb RL Jr, Gado M, Raichle ME. The effect of hemodynamically significant carotid artery disease on the hemodynamic status of the cerebral circulation. Ann Intern Med. 1987;106:27-35.
2. Balow J, Alter M, Resch JA. Cerebral thromboembolism: an appraisal of 100 cases. Neurology. 1966;16:559-564.
3. Pessin MS, Duncan GW, Mohr JP, Poskanser DC. Clinical and angiographic features of carotid transient ischemic attacks. N Eng J Med. 1977;296:358-362.
4. Thiele BL, Young JV, Chikos PM, Hirsch JH, Strandness DE Jr. Correlation of arteriographic findings and symptoms in cerebrovascular disease. Neurology. 1980;30:1041-1046.
5. Grubb RL Jr. Management of the patient with carotid occlusion and a single ischemic event. Clin Neurosurg. 1986;33:251-260.
6. Powers WJ. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol. 1991;29:231-240.
7. Klijn CJM, Rappelle LJ, Tulleken CAF, van Gijn J. Symptomatic carotid artery occlusion: a reappraisal of hemodynamic factors. Stroke. 1997;28:2084-2093.
8. Grubb RL Jr, Derdeyn CP, Fritsch SM, et al. The importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA. 1998;280:1055-1060.
9. Yamauchi H, Fukuyama Y, Nagahama Y, et al. Evidence of misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive diseases from PET. J Neurol Neurosurg Psychiatry. 1996;61:18-25.
10. EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial. N Engl J Med. 1985;313:1191-2000.
11. 15O positron emission tomography. Stroke. 1981;12:454-459.
12. Gibbs JM, Wise RJ, Thomas DJ, Mansfield AO, Russell RW. Cerebral haemodynamic changes after extracranial-intracranial bypass surgery. J Neurol Neurosurg Psychiatry. 1987;50:140-150.
13. Powers WJ, Martin WR, Herscovitch P, Raichle ME, Grubb RL Jr. Extracranial-intracranial bypass surgery: hemodynamic and metabolic effects. Neurology. 1984;34:1168-1174.
14. Hornberger J, Wrone E. When to base clinical policies on observational versus randomized trial data. Ann Intern Med. 1997;127:697-703.
15. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445-453.
16. Executive Committee of the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273:1421-1428.
17. Derdeyn CP, Yundt KD, Videen TO, Grubb RL Jr, Carpenter DA, Powers WJ. Increased oxygen extraction fraction is associated with prior ischemic events in patients with carotid occlusion. Stroke. 1998;29:754-758.
18. Eisenberg RL, Mani RL. Clinical and arteriographic comparison of amaurosis fugax with hemispheric transient ischemic attacks. Stroke. 1978;9:254-255.
19. Streifler JY, Eliasziw M, Benavente OR, et al. The risk of stroke in patients with first-ever retinal vs. hemispheric transient ischemic attacks and high grade carotid stenosis. Arch Neuro. 1998;62:246-249.
20. Beck JR, Pauker SG. The Markov process in medical prognosis. Med Decis Making. 1983;3:419-458.
21. Lipscomb J, Weinstein MC, Torrance GW. Time Preference. In: Gold MR, Siegel JE, Russel LB, Weinstein MC, eds. Cost Effectiveness in Medicine. New York, NY: Oxford University Press; 1996:214-246.
22. Derdeyn CP, Videen TO, Simmons NS, et al. Count-based PET method for predicting stroke in patients with symptomatic carotid occlusion. Radiology. 1999:212:449-506.
23. Derdeyn CP, Videen TO, Fritsch SM, et al. Compensatory mechanisms to chronic hypoperfusion in patients with carotid occlusion. Stroke. 1999;30:1019-1024.
24. Sacco RL, Wolf PA, Kannel WB, McNamara PM. Survival and recurrence following stroke. The Framingham study. Stroke. 1982;13:290-295.
25. Gage BF, Cardinalli AB, Albers GW, Owens DK. Cost effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA. 1995;275:1839-1845.
26. Dennis MS; Burn JPS, Sandercock PAG, Bamford JM, Wade DT, Warlow CP. Long-term survival after first-ever stroke: the Oxfordshire community stroke project. Stroke 1093;24:796-800.
27. Gage BF, Cardinalli AB, Owens DK. The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. Arch Intern Med. 1996;156:1829-1836.
28. Mark DB, Hlatky MA, Califf RM. et al. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med. 1995;332:1418-1424.
29. Fryback DG, Dasbach EJ, Klein R, et al. The Beaver Dam Health Outcomes Study: Initial catalog of health-state quality factors. Med Decis Making. 1993;13: 89-102.
30. Bureau of Labor Statistics. Available at: http://stats.bls.gov/cpihome.htm. Accessed May 5, 1998.
31. King JT, Glick HA, Mason TJ, Flamm ES. Elective surgery for asymptomatic, unrupture, intracranial aneurysms: a cost effectiveness analysis. J. Neurosurg. 1995;83:403-412.
32. Smurawaska LT, Alexandrov AV, Bladin CF, Norris JW. Cost of acute stroke care in Toronto. Canada. Stroke. 1994;25:1628-1631.
33. Hartunian N, Smart C, Thompson M. The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease, and stroke: a comparative analysis. Am J Public Health. 1980;70:1249-1260.
34. Thorngren M, Westling B. Utilization of health care resources after stroke. A population-based study of 258 hospitalized cases followed during the first year. Acta Neurol Scand. 1991;84:303-310.
35. Taylor TN, Davis PH, Torner JC, Holmes J, Meyer JW, Jacobson MF. Lifetime cost of stroke in the United States. Stroke. 1996;27:1459-1466.
36. Derdeyn CP, Powers WJ. Cost effectiveness of screening for asymptomatic carotid atherosclerotic disease. Stroke. 1996;27:1002-1005.
37. Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke. 1998;29:415-421.
38. Bogousslavsky J, Hachinski VC, Boughner DR, Fox AJ, Vinuela F. Barnett HJ. Cardiac and arterial lesions in transient ischemic attacks. Arch Neurol. 1986;43: 223-228.
39. Hsia DC, Moscoe LM, Krushat WM. Epidemiology of carotid endarterectomy among Medicare beneficiaries: 1985-1996 update. Stroke. 1998;29:346-350.
40. Karp HR, Randers WD, Shipp CC, Taylor B, Martin D. Carotid endarterectomy among Medicare beneficiaries: a statewide evaluation of appropriateness and outcome. Stroke. 1998;29:46-52.
41. Derdeyn CP, Grubb RL, Powers WJ. Cerebral hemodynamic impairment: methods of measurement and association with stroke risk. Neurology. 1999;53:251-259.
42. Institute for Clinical PET. Available at: http://www.icppet.org. Accessed Oct. 5, 1998.